טוען...
Rational Basis for Nutraceuticals in the Treatment of Glaucoma
BACKGROUND: Glaucoma, the second leading cause of blindness worldwide, is a chronic optic neuropathy characterized by progressive retinal ganglion cell (RGC) axons degeneration and death. Primary open-angle glaucoma (OAG), the most common type, is often associated with increased intraocular pressure...
שמור ב:
| הוצא לאור ב: | Curr Neuropharmacol |
|---|---|
| Main Authors: | , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Bentham Science Publishers
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6120110/ https://ncbi.nlm.nih.gov/pubmed/29119928 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X15666171109124520 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|